The effect of COVID-19 lockdown on glycemic control in patients with type 2 diabetes mellitus in Turkey

Basit Öğe Kaydı
dc.authoridOnmez, Attila/0000-0002-7188-7388
dc.contributor.authorOnmez, Attila
dc.contributor.authorGamsizkan, Zerrin
dc.contributor.authorOzdemir, Seyma
dc.contributor.authorKesikbas, Enis
dc.contributor.authorGokosmanoglu, Feyzi
dc.contributor.authorTorun, Serkan
dc.contributor.authorCinemre, Hakan
dc.date.accessioned2021-12-01T18:49:11Z
dc.date.available2021-12-01T18:49:11Z
dc.date.issued2020
dc.department[Belirlenecek]en_US
dc.description.abstractBackground and aims: A national lockdown to prevent the spread of coronavirus disease (COVID-19) in Turkey was introduced in March 2020. We think that lockdowns may lead to weight gain and worsening of glycemic parameters in patients with type 2 diabetes mellitus (DM). The purpose of this study was to investigate how type 2 DM patients were affected by the lockdown. Method: Type 2 DM patients unable to attend regular follow-ups due to lockdown over a 75-day period between March and June 2020 and who again attended polyclinic follow-up when the lockdown was lifted were included in the study. These patients' glycemic control and weight status were compared with the pre-lockdown period. In addition, patients' general habits, and adherence to diet and exercise were evaluated, while their general health was assessed using the Short-Form 36-item survey. Result: The research involved 101 type 2 DM patients, 57 men (56.5%) and 44 women (44.5%), with a mean age of 55 +/- 13. Patients' mean pre-lockdown weight was 84.7 +/- 16.4 kg, rising to 85.5 +/- 16.8 kg post-lockdown, although the increase was not statistically significant (p = 0.781). In terms of glycemic parameters, Hba1c rose from 7.67 +/- 1.76 to 8.11 +/- 2.48, and fasting glucose from 157.9 (83-645) mg/dl to 163.2 (84-550) mg/dl, none of which were statistically significant (p = 0.253, p = 0.079, respectively). Conclusion: In addition to weight gain among type 2 DM patients during the Covid 19 lockdown, statistically insignificant increases were also observed in such glycemic parameters. This was a small sample and further studies with larger sample are needed. (C) 2020 Diabetes India. Published by Elsevier Ltd. All rights reserved.en_US
dc.identifier.doi10.1016/j.dsx.2020.10.007
dc.identifier.endpage1966en_US
dc.identifier.issn1871-4021
dc.identifier.issn1878-0334
dc.identifier.issue6en_US
dc.identifier.pmid33059299en_US
dc.identifier.scopus2-s2.0-85092137636en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage1963en_US
dc.identifier.urihttps://doi.org/10.1016/j.dsx.2020.10.007
dc.identifier.urihttps://hdl.handle.net/20.500.12684/10679
dc.identifier.volume14en_US
dc.identifier.wosWOS:000605370300073en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakPubMeden_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherElsevier Sci Ltden_US
dc.relation.ispartofDiabetes & Metabolic Syndrome-Clinical Research & Reviewsen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectDiabetesen_US
dc.subjectLockdownen_US
dc.subjectOutbreaken_US
dc.subjectCovid 19en_US
dc.subjectSARS-cov 2en_US
dc.subjectSF-36en_US
dc.titleThe effect of COVID-19 lockdown on glycemic control in patients with type 2 diabetes mellitus in Turkeyen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
10679.pdf
Boyut:
2.57 MB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu